• The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis 

      Oikonomou E.K., Repanas T.I., Papanastasiou C., Kokkinidis D.G., Miligkos M., Feher A., Gupta D., Kampaktsis P.N. (2016)
      Background In-hospital acquired thrombocytopenia (TP) is relatively common among patients hospitalized with acute coronary syndromes (ACS). However, its effect on short-term and long-term outcomes has yet to be reviewed ...
    • Heparin induced thrombocytopenia diagnosis in cardiac surgery: Is there a role for thromboelastography? 

      Kouerinis, I. A.; Kourtesis, A.; El-Ali, M.; Sergentanis, T.; Plagou, A.; Argiriou, M.; Theakos, N.; Giannakopoulou, A. (2008)
      The aim of the present protocol is to investigate the potency of thromboelastography (TEG) to screen postcardiac heparin induced thrombocytopenia (HIT) patients suspicious for HIT type II, and to differentiate which of ...
    • Leptospirosis and pancytopenia: Two case reports and review of the literature 

      Stefos, A.; Georgiadou, S. P.; Gioti, C.; Loukopoulos, A.; Ioannou, M.; Pournaras, S.; Dalekos, G. N. (2005)
      Besides the classical manifestations, leptospirosis may rarely occur with erythroid hypoplasia and/or pancytopenia. In this study, we reported two cases of leptospirosis presented with pancytopenia as the prevailing ...
    • Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome 

      Diamantopoulos P.T., Charakopoulos E., Symeonidis A., Kotsianidis I., Viniou N.-A., Pappa V., Pontikoglou C., Tsokanas D., Drakos G., Kourakli A., Solomou E., Hatzimichael E., Pouli A., Kotsopoulou M., Asmanis E., Dimou M., Panayiotidis P., Papageorgiou S., Vassilopoulos G., Anagnostopoulos A., Vassilakopoulos T., Papadaki H., Galanopoulos A. (2022)
      Monocytopenia is a common finding in patients with myelodysplastic syndrome (MDS), but although monocytes may exhibit prognostic significance in MDS due to their role in innate immunity, they have not been incorporated in ...
    • Thrombolysis in stroke patients with elevated inflammatory markers 

      Altersberger V.L., Enz L.S., Sibolt G., Hametner C., Nannoni S., Heldner M.R., Stolp J., Jovanovic D.R., Zini A., Pezzini A., Wegener S., Cereda C.W., Ntaios G., Räty S., Gumbinger C., Heyse M., Polymeris A.A., Zietz A., Schaufelbuehl A., Strambo D., Padlina G., Slavova N., Tiainen M., Valkonen K., Velzen T.J., Bigliardi G., Stanarcevic P., Magoni M., Luft A., Bejot Y., Vandelli L., Padjen V., Nederkoorn P.J., Arnold M., Michel P., Ringleb P.A., Curtze S., Engelter S.T., Gensicke H., for the Thrombolysis in Stroke Patients (TRISP) collaborators (2022)
      Objective: To investigate the prognostic value of white blood cell count (WBC) on functional outcome, mortality and bleeding risk in stroke patients treated with intravenous thrombolysis (IVT). Methods: In this prospective ...